Skip to main content
SpringerLink
Log in

Human immune response to monoclonal antibody-enzyme conjugates in ADEPT pilot clinical trial

  • Published:
Cell Biophysics Aims and scope Submit manuscript

Abstract

The human immune response to monoclonal antibody-enzyme conjugates has been studied in patients included in the pilot clinical trial of ADEPT. Each patient received murine monoclonal anti-CEA antibody fragments (A5B7-F(ab')2, conjugated to bacterial enzyme, carboxypeptidase G2 (CPG2) followed by a galactosylated monoclonal anti-CPG2 antibody (SB43), 36–48 h after the conjugate. Some patients were also given a dose of131I-labeled conjugate (4–8 mg, 7–15 mCi) for blood clearance and gamma camera image studies. All patients studied developed human antimouse antibodies (HAMA) and anti-CPG2 antibodies within 10 d after a single course of treatment with the conjugate. In most cases, IgM response was detected at 7 d after the conjugate followed by the IgG response 14 d later. In one patient, HAMA and anti-CPG2 antibodies of the IgG type could still be detected at 10 mo after treatment. Anti-CPG2 antibodies in serum of one patient were found to inhibit CPG2 activity in vitro.

Generation of neutralizing antibodies limits the use of repeat cycles of ADEPT in patients. Use of immunosuppressive agents may allow a useful time window for several ADEPT cycle treatments by delaying the appearance of HAMA and anti-CPG2 antibodies. Patients given cyclosporin A before and during ADEPT are currently being studied for HAMA and anti-CPG2 response.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Bagshawe, K. D. (1987) Antibody directed enzymes revive anticancer prodrugs concept.Br. J. Cancer 56, 531,532.

    Google Scholar 

  2. Bagshawe, K. D., Springer, C. J., Searle, F., Antoniw, P., Sharma, S. K., Melton, R. G., and Sherwood, R. F. (1988) A cytotoxic agent can be generated selectively at cancer sites.Br. J. Cancer 58, 700–703.

    PubMed  CAS  Google Scholar 

  3. Senter, P. D., Saulnier, M. G., Schreiber, G. J., Hirschberg, D. L., Brown, J. P., Hellstrom, I. N., and Hellstrom, K. E. (1988) Anti-tumour effects of antibody-alkaline-phosphatase conjugates in combination with etoposide phosphate.Proc. Natl. Acad. Sci. USA 85, 4842–4846.

    Article  PubMed  CAS  Google Scholar 

  4. Springer, C. J., Antoniw, P., Bagshawe, K. D., Searle, F., Bissett, G. M. F., and Jarman, M. (1990) Novel prodrugs which are activated to cytotoxic alkylating agents by carboxypeptidase G2.J. Med. Chem. 33, 677–681.

    Article  PubMed  CAS  Google Scholar 

  5. Bagshawe, K. D. (1989) Towards generating cytotoxic agents at cancer sites. The First Bagshawe Lecture.Br. J. Cancer 60, 275–281.

    PubMed  CAS  Google Scholar 

  6. Sharma, S. K., Bagshawe K. D., Springer, C. J., Burke, P. J., Rogers, G. T., Boden, J. A., Antoniw, P., Melton, R. G., and Sherwood, R. F. (1991) Antibody directed enzyme prodrug therapy (ADEPT): A three-phase system.Disease Markers 9, 225–231.

    PubMed  CAS  Google Scholar 

  7. Courtenay-Luck, N. S., Epenetos, A. A., Moore, R., Larche, M., Pectasides, D., Dhokia, B., and Ritter, M. A. (1986) Development of primary and secondary immune response to mouse monoclonal antibodies used in the diagnosis and therapy of malignant neoplasms.Cancer Res. 46, 6489–6493.

    PubMed  CAS  Google Scholar 

  8. Schroff, R. W., Foon, K. A., Beatty, S., Oldham, R. K., and Morgan, A. C. (1985) Human anti-murine immunoglobulin responses in patients receiving monoclonal antibody therapy.Cancer Res. 45, 879–885.

    PubMed  CAS  Google Scholar 

  9. Shawler, D. L., Bartholomew, R. M., Smith, L. M., and Dillman, R. O. (1985) Human immune response to multiple injections of murine IgG1.J. Immunol. 135, 1530–1535.

    PubMed  CAS  Google Scholar 

  10. LoBuglio, A. F., Wheeler, R. H., Trang, J., Haynes, A., Rogers, K., Harvey, E. B., Sun, L., Ghrayeb, J., and Khazaeli, M. B. (1989) Mouse/human chimeric monoclonal antibody in man: kinetics and immune response.Proc. Natl. Acad. Sci. USA 86, 4220–4224.

    Article  PubMed  CAS  Google Scholar 

  11. Meredith, R. F., LoBuglio, A. F., Plott, W. E., Orr, R. A., Brezovich, I. A., Russell, C. D., Harvey, E. B., Yester, M. V., Wagner, A. J., Spencer, S. A., Wheeler, R. H., Saleh, M. N., Rogers, K. J., Polansky, A., Salter, M. M., and Khazaeli, M. B. (1991) Pharmacokinetics, immune response and biodistribution of iodine-131-labeled chimeric Mouse/human IgG1, k 17-1A monoclonal antibody.J. Nucl. Med. 32, 1162–1168.

    PubMed  CAS  Google Scholar 

  12. Morrison, S. L. (1985) Transfectomas provide novel chimeric antibodies.Science (Washington, DC) 229, 1202–1207.

    Article  CAS  Google Scholar 

  13. Reichman, L. C. M., Waldmann, H., and Winter, G. (1988) Reshaping human antibodies for therapy.Nature 332, 323–327.

    Article  Google Scholar 

  14. Haspel, M. V., McCabe, R. P., Pomato, N., Janesh, N. J., Knowlton, J. V., Peters, L. C., Hoover, H. C. Jr., and Hanna, M. G. Jr. (1985) Generation of tumour cell reactive monoclonal antibodies using peripheral blood lymphocytes from actively immunised colorectal carcinoma patients.Cancer Res. 45, 3951–3961.

    PubMed  CAS  Google Scholar 

  15. McCabe, R. P., Peters, L. C., Haspel, M. V., Pomato, N., Carrasquillo, J. A., and Hanna, M. G. Jr. (1988) Preclinical studies on the pharmacokinetic properties of human monoclonal antibodies to colorectal cancer and their use for detection of tumours.Cancer Res. 48, 4348–4353.

    PubMed  CAS  Google Scholar 

  16. Bosslet, K., Czech, J., Lorenz, P., Sedlacek, H. H., Schuermann, M., and Seeman, G. (1992) Molecular and functional characterisation of a fusion protein suited for tumour specific prodrug activation.Br. J. Cancer 65, 234–238.

    PubMed  CAS  Google Scholar 

  17. Sherwood, R. F., Melton, R. G., Alwan, S. M., and Hughes, P. (1985) Purification and properties of carboxypeptidase G2 from Pseudomonas sp. strain RS16: use of a novel triazine dye affinity method.Eur. J. Biochem. 148, 453–477.

    Article  Google Scholar 

  18. Melton, R. G., Boyle, J. M. B., Rogers, G. T., Burke, P., Bagshawe, K. D., and Sherwood, R. F. (1993) Optimisation of small-scale coupling of A5B7 monoclonal antibody to carboxypeptidase G2.J. Immunol. Meth. 158, 49–56.

    Article  CAS  Google Scholar 

  19. Sharma, S. K., Bagshawe, K. D., Burke, P. J., Boden, R. W., and Rogers, G. T. (1990) Inactivation and clearance of an anti-CEA carboxypeptidase G2 conjugate in blood after localisation in a xenograft model.Br. J. Cancer 61, 659–662.

    PubMed  CAS  Google Scholar 

  20. Mattes, M. J. (1987) Biodistribution of antibodies after intraperitoneal or intravenous injection and effect of carbohydrate modifications.J. Natl. Cancer Inst. 79, 855.

    PubMed  CAS  Google Scholar 

  21. Springer, C. J., Bagshawe, K. D., Sharma, S. K., Searle, F., Boden, J. A., Antoniw, P., Burke, P. J., Rogers, G. T., Sherwood, R. F., and Melton, R. G. (1991) Ablation of human choriocarcinoma xenografts in nude mice by antibody directed enzyme prodrug therapy (ADEPT) with three novel compounds.Eur. J. Cancer 27, 1361–1366.

    Article  PubMed  CAS  Google Scholar 

  22. Bagshawe, K. D., Sharma, S. K., Springer, C. J. S., Antoniw, P., Boden, J. A., Roger, G. T., Burke, P. J., Melton, R. G., and Sherwood, R. F. (1991) Antibody directed enzyme prodrug therapy (ADEPT): clinical report.Disease Markers 9, 233–238.

    PubMed  CAS  Google Scholar 

  23. Blottiere, H. M., Douillard, J. Y., Koprowski, H., and Steplewski, Z. (1990) Immunoglobulin class and immunoglobulin G subclass analysis of human antimouse antibody response during monoclonal antibody treatment of cancer patients.Cancer Res. 50(Suppl.), 1051–1054.

    Google Scholar 

  24. Sharma, S. K., Bagshawe, K. D., Melton, R. G., and Sherwood, R. F. (1991) Immunogenicity of monoclonal antibody-enzyme conjugates in antibody directed enzyme prodrug therapy (ADEPT) [Abstract].Antibody, Immunoconjugates and Radiopharmaceuticals 4, 226.

    Google Scholar 

  25. Ledermann, J. A., Begent, R. H. J., Bagshawe, K. D., Riggs, S. J., Searle, F., Glaser, M. G., Green, A. J., and Dale, R. G. (1988) Repeated antitumor antibody therapy in man with suppression of the host response to Cyclosporin A.Br. J. Cancer 58, 654–657.

    PubMed  CAS  Google Scholar 

  26. Kino, T., Hatanaka, H., and Miyata, S. (1987) FK 506, a novel immunosuppressant isolated from streptomyces. II. Immunosuppressive effect of FK506 in vivo.J. Antibiot. Tokyo 40, 1526–1565.

    Google Scholar 

  27. Waldmann, H. (1989) Manipulation of T cell responses with monoclonal antibodies.Ann. Rev. Immunol. 7, 407–444.

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. CRC Labs, Department of Medical Oncology, Charing Cross Hospital, Fulham Palace Road, W6, London, UK

    Surinder K. Sharma & Kenneth D. Bagshawe

  2. Division of Biotechnology, PHLS, CAMR, Porton Down, Salisbury, Wiltshire, UK

    Roger G. Melton & Roger F. Sherwood

Authors
  1. Surinder K. Sharma
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Kenneth D. Bagshawe
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Roger G. Melton
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Roger F. Sherwood
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Sharma, S.K., Bagshawe, K.D., Melton, R.G. et al. Human immune response to monoclonal antibody-enzyme conjugates in ADEPT pilot clinical trial. Cell Biophysics 21, 109–120 (1992). https://doi.org/10.1007/BF02789482

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02789482

Index Entries

Search

Navigation